Jump to content

Pfizer kept quiet about a drug that could potentially reduce the risk of Alzheimer’s, WaPo Saya


Recommended Posts

Posted

According to the report, Pfizer discovered that rheumatoid arthritis drug Enbrel appeared to reduce the risk of Alzheimer’s disease by 64 percent. The company decided not to pursue the clinical trial due to high costs and chose not to make the data public.

D8QqxUfWsAEkoef.jpg

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...